{"id":"https://openalex.org/W1979080372","doi":"https://doi.org/10.1097/coc.0b013e31818f2d2f","title":"Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy","display_name":"Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy","publication_year":2009,"publication_date":"2009-08-01","ids":{"openalex":"https://openalex.org/W1979080372","doi":"https://doi.org/10.1097/coc.0b013e31818f2d2f","mag":"1979080372","pmid":"https://pubmed.ncbi.nlm.nih.gov/19487917"},"language":"en","primary_location":{"id":"doi:10.1097/coc.0b013e31818f2d2f","doi":"https://doi.org/10.1097/coc.0b013e31818f2d2f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e31818f2d2f","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012804079","display_name":"P. Fumoleau","orcid":"https://orcid.org/0000-0002-2912-2170","observed_orcids":["https://orcid.org/0000-0002-2912-2170"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Pierre Fumoleau","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113610330","display_name":"H. Cort\u00e9s-Funes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Hernan Cort\u00e9s-Funes","raw_affiliation_strings":["Hospital Universitario 12 de Octubre, Madrid, Spain","Wilgers Hospital, Pretoria, Republic of South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]},{"raw_affiliation_string":"Wilgers Hospital, Pretoria, Republic of South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111558059","display_name":"Amina B. Taleb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Amina B. Taleb","raw_affiliation_strings":["Institut Salah Aza\u00efz, Tunis, Tunisia","Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Salah Aza\u00efz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597"]},{"raw_affiliation_string":"Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056471340","display_name":"Stephen Y.T. Chan","orcid":"https://orcid.org/0000-0001-8865-6618","observed_orcids":["https://orcid.org/0000-0001-8865-6618","https://orcid.org/0000-0001-8998-5480"]},"institutions":[{"id":"https://openalex.org/I2802921333","display_name":"Nottingham City Hospital","ror":"https://ror.org/0022b3c04","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I2802921333"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Chan","raw_affiliation_strings":["Nottingham City Hospital, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham City Hospital, Nottingham, UK","institution_ids":["https://openalex.org/I2802921333"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071553983","display_name":"Mario Campone","orcid":"https://orcid.org/0000-0002-5196-5908","observed_orcids":["https://orcid.org/0000-0002-5196-5908"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Campone","raw_affiliation_strings":["Centre Ren\u00e9 Gauducheau, Nantes-Saint-Herblain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Gauducheau, Nantes-Saint-Herblain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jean-Christophe Pouget","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Jean-Christophe Pouget","raw_affiliation_strings":["Institut Salah Aza\u00efz, Tunis, Tunisia","Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Salah Aza\u00efz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597"]},{"raw_affiliation_string":"Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012336750","display_name":"Michele Tubiana-Hulin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mich\u00e8le Tubiana-Hulin","raw_affiliation_strings":["Centre Ren\u00e9 Huguenin, Saint-Cloud, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Huguenin, Saint-Cloud, France","institution_ids":["https://openalex.org/I4210116453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103685749","display_name":"C F Slabber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802675445","display_name":"Steve Biko Hospital","ror":"https://ror.org/015gtm372","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I2802675445"]},{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR","ZA"],"is_corresponding":true,"raw_author_name":"Conrad F. Slabber","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","Pretoria Academic Hospital, Pretoria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"Pretoria Academic Hospital, Pretoria","institution_ids":["https://openalex.org/I2802675445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011115159","display_name":"I. Caroff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090597","display_name":"Institut Salah-Aza\u00efz","ror":"https://ror.org/00brjxm92","country_code":"TN","type":"healthcare","lineage":["https://openalex.org/I4210090597"]},{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR","TN"],"is_corresponding":false,"raw_author_name":"Isabelle Caroff-Para\u00efso","raw_affiliation_strings":["Institut Salah Aza\u00efz, Tunis, Tunisia","Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Salah Aza\u00efz, Tunis, Tunisia","institution_ids":["https://openalex.org/I4210090597"]},{"raw_affiliation_string":"Institut de Recherche Pierre Fabre, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109227691","display_name":"Albert S. Alberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert S. Alberts","raw_affiliation_strings":["Hospital Universitario 12 de Octubre, Madrid, Spain","Wilgers Hospital, Pretoria, Republic of South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]},{"raw_affiliation_string":"Wilgers Hospital, Pretoria, Republic of South Africa","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108653636","display_name":"Farhat Ben Ayed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farhat Ben Ayed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5012804079","https://openalex.org/A5103685749"],"corresponding_institution_ids":["https://openalex.org/I2802675445","https://openalex.org/I4210094685"],"apc_list":null,"apc_paid":null,"fwci":3.1602,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.91568462,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"32","issue":"4","first_page":"375","last_page":"380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vinflunine","display_name":"vinflunine","score":0.996999979019165},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/third-line-chemotherapy","display_name":"third-line chemotherapy","score":0.9020000100135803},{"id":"https://openalex.org/keywords/anthracycline-refractory-disease","display_name":"anthracycline-refractory disease","score":0.847000002861023},{"id":"https://openalex.org/keywords/taxane-refractory-disease","display_name":"taxane-refractory disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.6330000162124634},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.7120000123977661},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9869999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7620000243186951},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9440156817436218},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.8991341590881348},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.863044023513794},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6804654598236084},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6677173376083374},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6598730087280273},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5660939812660217},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5072514414787292},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4295036792755127},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4214448630809784}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/coc.0b013e31818f2d2f","doi":"https://doi.org/10.1097/coc.0b013e31818f2d2f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e31818f2d2f","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:19487917","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19487917","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W336115799","https://openalex.org/W1564873415","https://openalex.org/W1828283074","https://openalex.org/W1939003096","https://openalex.org/W1966574632","https://openalex.org/W1972362283","https://openalex.org/W1976487179","https://openalex.org/W1984254136","https://openalex.org/W2004853608","https://openalex.org/W2015159040","https://openalex.org/W2037174072","https://openalex.org/W2053123405","https://openalex.org/W2064885466","https://openalex.org/W2066984265","https://openalex.org/W2069284637","https://openalex.org/W2072735451","https://openalex.org/W2074017390","https://openalex.org/W2078958774","https://openalex.org/W2103221219","https://openalex.org/W2113101214","https://openalex.org/W2119609398","https://openalex.org/W2123732467","https://openalex.org/W2127922599","https://openalex.org/W2143399650","https://openalex.org/W2143435580","https://openalex.org/W2144727586","https://openalex.org/W2145042104","https://openalex.org/W2168987104","https://openalex.org/W2295204405","https://openalex.org/W6841321355"],"related_works":["https://openalex.org/W2072735451","https://openalex.org/W2245118714","https://openalex.org/W2792995487","https://openalex.org/W2070409805","https://openalex.org/W2526703400","https://openalex.org/W2087025815","https://openalex.org/W2166000151","https://openalex.org/W3165775251","https://openalex.org/W1755746957","https://openalex.org/W1974628899"],"abstract_inverted_index":{"OBJECTIVE:":[0],"A":[1],"multicenter,":[2],"open-label,":[3],"phase":[4],"2":[5,43],"study":[6],"evaluated":[7],"the":[8,76,93,108,149,161,245],"efficacy":[9],"and":[10,30,52,84,95,105,177,195,209,216,230],"safety":[11],"of":[12,28,57,65,107,126,134,160,172,180,222,228,238,247],"intravenous":[13],"vinflunine":[14,58,206,239],"as":[15,219],"third-line":[16,220],"treatment":[17,221,246],"in":[18,92,103,158,166,170,242],"patients":[19,37,223],"with":[20,38,121,154,205,224],"progressing":[21],"metastatic":[22],"breast":[23],"cancer":[24],"(MBC)":[25],"after":[26,41,226],"failure":[27,227],"anthracycline-":[29,229],"taxane-based":[31,231],"chemotherapy.":[32],"PATIENTS":[33],"AND":[34],"METHODS:":[35],"Fifty-six":[36],"MBC,":[39],"relapsing":[40],"receiving":[42],"previous":[44],"treatments":[45],"for":[46,244],"advanced":[47],"disease,":[48],"including":[49],"both":[50],"anthracyclines":[51],"taxanes,":[53],"received":[54],"320":[55],"mg/m(2)":[56],"once":[59],"every":[60],"3":[61,164,188],"weeks":[62],"(median":[63],"number":[64],"2.5":[66],"cycles,":[67],"range:":[68],"1-13).":[69],"RESULTS:":[70],"According":[71],"to":[72],"an":[73,214],"independent":[74],"radiologist,":[75],"response":[77,135],"rate":[78],"was":[79,101,114,136,148],"12.5%":[80],"(95%":[81,86,117,129,139],"CI:":[82,87,118,130,140],"5.2-24.1)":[83],"14%":[85],"5.3-27.9)":[88],"(6":[89],"partial":[90],"responses)":[91],"treated":[94],"evaluable":[96],"populations,":[97],"respectively.":[98,110],"Disease":[99],"control":[100],"achieved":[102],"42.9%":[104],"51.2%":[106],"patients,":[109,173],"Median":[111],"progression-free":[112],"survival":[113,125],"2.6":[115],"months":[116,128,138],"1.6-4.0":[119],"months)":[120],"a":[122],"median":[123],"overall":[124],"11.4":[127],"7.4-14.2":[131],"months).":[132],"Duration":[133],"6.8":[137],"5.6":[141],"months,":[142],"upper":[143],"limit":[144],"not":[145],"reached).":[146],"Leukopenia":[147],"most":[150],"frequent":[151],"hematologic":[152],"toxicity,":[153],"grade":[155,168,187],"3/4":[156],"severity":[157],"49.1%":[159],"patients.":[162],"Grade":[163],"neutropenia":[165,175,181],"30.9%,":[167],"4":[169],"40.0%":[171],"febrile":[174],"(5.4%),":[176],"1":[178],"case":[179],"infection":[182],"(1.8%)":[183],"were":[184,199,207],"reported.":[185],"Other":[186],"toxicities":[189],"included":[190],"anemia":[191],"(5.5%),":[192],"fatigue":[193],"(14.3%),":[194],"constipation":[196],"(7.1%),":[197],"which":[198],"noncumulative.":[200],"The":[201],"adverse":[202],"events":[203],"associated":[204],"predictable":[208],"manageable.":[210],"CONCLUSIONS:":[211],"Vinflunine":[212],"is":[213],"active":[215],"well-tolerated":[217],"agent":[218],"MBC":[225],"therapy.":[232],"These":[233],"results":[234],"warrant":[235],"further":[236],"investigation":[237],"monotherapy":[240],"or":[241],"combination":[243],"MBC.":[248]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}